Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-17-016847

Options or other derivatives

  • Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SAMPAT MAYANK D. Director 2017-03-23 Grant or award · Share Option (Right to Buy) +2,500 2,500 D
Loading xslF345X03/v462726_4.xml…